|
Journal of Histochemistry and Cytochemistry, Vol. 49, 519-528, April 2001, Copyright © 2001, The Histochemical Society, Inc.
Identification and Purification of Functional Human ß-cells by a New Specific Zinc-fluorescent Probe
Bruno Lukowiaka,
Brigitte Vandewallea,
Rita Riachya,
Julie KerrContea,
Valery Gmyra,
Sandrine Belaicha,
Jean Lefebvrea, and
François Pattoua
a UPRS 1048/ERITMINSERM, Université de Lille, Lille, France
Correspondence to:
Brigitte Vandewalle, UPRES 1048/ERITMINSERM, Université de Lille, 1 Place de Verdun, 59045 Lille, France. E-mail: bvandewalle@univ-lille2.fr
Pancreatic ß-cells contain large amounts of zinc. We took advantage of this to try to localize, quantify, and isolate insulin-producing cells from islet preparations. Our study was designed to identify a non-toxic zinc-sensitive fluorescent probe able to selectively label labile zinc in viable ß-cells and to exhibit excitation and emission wavelengths in the visible spectrum, making this technique exploitable by most instruments. We tested Newport Green, a probe excitable at 485 nm with a dissociation constant in the micromolar range corresponding to a low affinity for zinc. The loading of the lipophilic esterified form of Newport Green was easy, rapid, specific, and non-toxic to cells. Confocal microscopy highlighted an intense fluorescence associated with secretory granules. Regression analyses showed a good relationship between zinc fluorescence and islet number (r=0.98) and between zinc fluorescence and insulin content (r=0.81). The determination of Zn fluorescence per DNA enabled us to assess the quality of the different islet preparations intended for islet allografting in terms of both purity and viability. Cell sorting of dissociated Newport Green-labeled cells resulted in a clear separation of ß-cells, as judged by insulin content per DNA and immunocytochemical analysis. This zinc probe, the first able to specifically label living cells in the visible spectrum, appears very promising for ß-cell experimentation, both clinically and for basic research. (J Histochem Cytochem 49:519527, 2001)
Key Words:
human pancreatic ß-cell identification, human pancreatic islet purification, fluorescence-activated cell sorting, zinc-sensitive fluorescent probe

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Boni-Schnetzler, J. Thorne, G. Parnaud, L. Marselli, J. A. Ehses, J. Kerr-Conte, F. Pattou, P. A. Halban, G. C. Weir, and M. Y. Donath
Increased Interleukin (IL)-1{beta} Messenger Ribonucleic Acid Expression in {beta}-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1{beta} in Human Islets by Glucose and Autostimulation
J. Clin. Endocrinol. Metab.,
October 1, 2008;
93(10):
4065 - 4074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Bauer, H. Nilsson, E. Thulin, B. Frohm, J. Malm, and S. Linse
Zn2+ binding to human calbindin D28k and the role of histidine residues
Protein Sci.,
April 1, 2008;
17(4):
760 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Koshkin, F. F. Dai, C. A. Robson-Doucette, C. B. Chan, and M. B. Wheeler
Limited Mitochondrial Permeabilization Is an Early Manifestation of Palmitate-induced Lipotoxicity in Pancreatic {beta}-Cells
J. Biol. Chem.,
March 21, 2008;
283(12):
7936 - 7948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jang, H. Wang, J. Xi, R. A. Mueller, E. A. Norfleet, and Z. Xu
NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes
Cardiovasc Res,
July 15, 2007;
75(2):
426 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Chimienti, S. Devergnas, F. Pattou, F. Schuit, R. Garcia-Cuenca, B. Vandewalle, J. Kerr-Conte, L. Van Lommel, D. Grunwald, A. Favier, et al.
In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion
J. Cell Sci.,
October 15, 2006;
119(20):
4199 - 4206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lalloyer, B. Vandewalle, F. Percevault, G. Torpier, J. Kerr-Conte, M. Oosterveer, R. Paumelle, J.-C. Fruchart, F. Kuipers, F. Pattou, et al.
Peroxisome Proliferator-Activated Receptor {alpha} Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets
Diabetes,
June 1, 2006;
55(6):
1605 - 1613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Neve, M. E. Fernandez-Zapico, V. Ashkenazi-Katalan, C. Dina, Y. H. Hamid, E. Joly, E. Vaillant, Y. Benmezroua, E. Durand, N. Bakaher, et al.
From The Cover: Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function
PNAS,
March 29, 2005;
102(13):
4807 - 4812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Eeckhoute, E. Moerman, T. Bouckenooghe, B. Lukoviak, F. Pattou, P. Formstecher, J. Kerr-Conte, B. Vandewalle, and B. Laine
Hepatocyte Nuclear Factor 4{alpha} Isoforms Originated from the P1 Promoter Are Expressed in Human Pancreatic {beta}-Cells and Exhibit Stronger Transcriptional Potentials than P2 Promoter-Driven Isoforms
Endocrinology,
May 1, 2003;
144(5):
1686 - 1694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Riachy, B. Vandewalle, J. Kerr Conte, E. Moerman, P. Sacchetti, B. Lukowiak, V. Gmyr, T. Bouckenooghe, M. Dubois, and F. Pattou
1,25-Dihydroxyvitamin D3 Protects RINm5F and Human Islet Cells against Cytokine-Induced Apoptosis: Implication of the Antiapoptotic Protein A20
Endocrinology,
December 1, 2002;
143(12):
4809 - 4819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shiroi, M. Yoshikawa, H. Yokota, H. Fukui, S. Ishizaka, K. Tatsumi, and Y. Takahashi
Identification of Insulin-Producing Cells Derived from Embryonic Stem Cells by Zinc-Chelating Dithizone
Stem Cells,
July 1, 2002;
20(4):
284 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2001
|
|
|